REGULATORY

• Pediatric Use of 3 ITP Drugs Near Official Approval in Japan
  November 1, 2024

• Govt’s Council Calls for Pushing Drug Innovation, Generic Revamp
  October 31, 2024

• BeiGene’s Brukinsa, J&J’s Balversa and More Now in Line for Japan Approval
  October 31, 2024

• LDP’s Hashimoto Regrets Election Defeat amid Off-Year Debate
  October 30, 2024

• Ruling Bloc’s Loss of Lower House Majority Might Sway Off-Year Revision Debates
  October 29, 2024

• LDP Loses Big in Snap Election, Many Health-Savvy Members Ousted
  October 28, 2024

• MHLW Lists Up 78 Drug-Loss Assets, Asks Makers to Report Any Hurdles in Development
  October 28, 2024

• No New Safety Concerns for COVID-19 Vaccines in Japan: Experts
  October 28, 2024

• MHLW to Update List of “Stable Supply Medicines” Eyeing Expansion
  October 25, 2024

• MHLW Announces Revisions to Conditional Approval Rules
  October 25, 2024

• MHLW Outlines Envisaged Cases of Regulatory Submissions without Japanese Data, Covering Rare Disease Drugs
  October 24, 2024

• Contribution to Drug Discovery Up for Discussion in Revising Core Hospital Criteria
  October 24, 2024

• Marukawa Touts Importance of Drug Innovation in Lower House Campaign
  October 24, 2024

• LDP’s Hashimoto Makes Rare Speech on Drug Prices amid Close Race in Okayama
  October 22, 2024

• Ex-Health Minister Gets Kostaive Shot, Warns against “Unscientific Concerns”
  October 21, 2024

• ITP Pediatric Dosage Approvals on Agenda of MHLW Panel for Oct. 31
  October 18, 2024

• MHLW Panel to Review BeiGene’s 1st Drug Candidate in Japan and More on Oct. 30
  October 17, 2024

• Multiple Candidates Tout Drug Policies as Snap Poll Campaigning Starts
  October 16, 2024

• MHLW to Run Follow-Up Survey on Updated Commercial Guidelines, Solo Distribution
  October 15, 2024

• Japan Political Parties Push Varied Pharma Policies as Election Campaign Kicks Off
  October 15, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 36
• 37
• 38
• 39
• 40
• 41
• 42
• 43
• 44
• …
• Next ›
• 最終 »